Alvimopan, a perpherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery

Eugene R. Viscusi(Thomas Jefferson University), B. Wallin(Cubist Pharmaceuticals (United States)), Angelo Andonakakis(Thomas Jefferson University), Thomas A. Witkowski(Thomas Jefferson University), Samuel Goldstein(Thomas Jefferson University), Wei Du(Cubist Pharmaceuticals (United States)), Lee Techner(Tsumura Research Institute (Japan)), R. Jan(Thomas Jefferson University), K. Gabriel(Thomas Jefferson University)
Surgical Endoscopy
February 14, 2006
Cited by 1


Related Papers